Abstract
Following its implementation in the 1960s, fluorescein angiography (FA) has become a widely used and reliable tool in the diagnosis of retinal and choroidal disorders. FA is an imaging modality utilized to examine the circulation of the retina and choroid. Here, we describe the process of obtaining fundus images with sodium fluorescein dye as a contrast agent. Using this methodology, ophthalmologists may examine the retinal and choroidal vasculature to diagnose a wide scope of retinal and choroidal diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baeyer A (1871) Uber ein neue Klasse van farbstoffen. Der Deutschen Chem Ges 4:555
Ehrlich P (1882) Uber provilirte fluoresceinzerscheinungen. Am Aug Dtsch Med Wochenschr:8–21
Burke A (1910) Die klinische physiologische und pathologie bedeuting der fluorescein im auge nach darrerching von-uranin. Klin Monatsbl Augenheilkd 48:445–454
Gass JDM, Sever RJ, Sparks D et al (1967) A combined technique of fluorescein fundoscopy and angiography of the eye. Arch Ophthalmol 78:455–461
Arevalo JF (2009) Retinal angiography and optical coherence tomography. Springer, pp 1–471
Bloome MA (1980) Fluorescein angiography: risks. Vis Res 20:1083–1097
Kelley JS (1977) Fluorescein angiography: techniques and toxicity. Int Ophthalmol Clin 17:25–33
Jennings BJ, Mathews DE (1994) Adverse reactions during retinal fluorescein angiography. J Am Optom Assoc 65:465–471
Yannuzzi LA, Rohrer KT, Tindel LJ et al (1986) Fluorescein angiography complication survey. Ophthalmology 93:611–617
Halperin LS, Olk J, Soubrane G et al (1990) Safety of fluorescein angiography during pregnancy. Am J Ophthalmol 109:563–566
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Ethics declarations
Stephen H. Tsang receives financial support from Abeona Therapeutics, Inc and Emendo. He is also the founder of Rejuvitas and is on the scientific and clinical advisory board for Nanoscope Therapeutics.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Baddam, D.O., Ragi, S.D., Tsang, S.H., Ngo, W.K. (2023). Ophthalmic Fluorescein Angiography. In: Tsang, S.H., Quinn, P.M. (eds) Retinitis Pigmentosa. Methods in Molecular Biology, vol 2560. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2651-1_15
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2651-1_15
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2650-4
Online ISBN: 978-1-0716-2651-1
eBook Packages: Springer Protocols